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ABSTRACT
Objectives Identify barriers and facilitators to integrating
community tuberculosis screening with mobile X-ray units
into a health system.
Methods Reach, effectiveness, adoption, implementation
and maintenance evaluation.
Setting 3-district region of Lima, Peru.
Participants 63 899 people attended the mobile units
from 7 February 2019 to 6 February 2020.
Interventions Participants were screened by chest
radiography, which was scored for abnormality by
computer-aided detection. People with abnormal X-rays
were evaluated clinically and by GeneXpert MTB/RIF
(Xpert) sputum testing. People diagnosed with tuberculosis
at the mobile unit were accompanied to health facilities for
treatment initiation.
Primary and secondary outcome measures Reach was
defined as the percentage of the population of the three-
district region that attended the mobile units. Effectiveness
was defined as the change in tuberculosis case
notifications over a historical baseline. Key implementation
fidelity indicators were the percentages of people who had
chest radiography performed, were evaluated clinically,
had sputum samples collected, had valid Xpert results and
initiated treatment.
Results The intervention reached 6% of the target
population and was associated with an 11% (95% CI 6 to
16) increase in quarterly case notifications, adjusting for
the increasing trend in notifications over the previous 3
years. Implementation indicators for screening, sputum
collection and Xpert testing procedures all exceeded 85%.
Only 82% of people diagnosed with tuberculosis at the
mobile units received treatment; people with negative or
trace Xpert results were less likely to receive treatment.
Suboptimal treatment initiation was driven by health
facility doctors’ lack of familiarity with Xpert and lack of
confidence in diagnoses made at the mobile unit.
Conclusion Mobile X-ray units were a feasible and
effective strategy to extend tuberculosis diagnostic
services into communities and improve early case
detection. Effective deployment however requires advance

Strengths and limitations of this study
►► An implementation science evaluation of a large

programme that screened over 60 000 people for
tuberculosis in a middle-income country allowed us
to both assess the performance of the programme
and draw conclusions about how to incorporate mobile X-ray units for tuberculosis screening into existing health systems in similar settings.
►► Individual-level programmatic data allowed us not
only to assess overall reach and implementation
fidelity but also to analyse heterogeneity in these
areas.
►► The assessment of effectiveness adjusts for temporal trends but is limited by an inability to control
for the effects of other programme or population
changes that might have contributed to increased
case notifications.
►► The assessment of adoption and maintenance is
limited by a reliance on secondary data sources
rather than focus groups or interviews.

coordination among stakeholders and targeted provider
training to ensure that people diagnosed with tuberculosis
by new modalities receive prompt treatment.

INTRODUCTION
Globally, around 10 million people develop
tuberculosis (TB) each year, and up to 30% of
people who develop TB each year are not diagnosed and treated.1 While better diagnostic
technologies and treatments are urgently
needed, underutilisation of strategies with
demonstrated effectiveness also contributes
to the slow pace of decline in global TB incidence.2 One such strategy is targeted active
case finding, where health systems seek out
people at high risk for TB through screening
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METHODS
We conducted a reach, effectiveness, adoption, implementation and maintenance (RE-AIM) evaluation14 of the
first year of implementation of TB Móvil, a programme
that uses mobile screening units with X-ray vans for TB
active case finding in community settings. TB Móvil is an
ongoing programme that is part of the Zero TB Initiative,15 an alliance of implementers committed to creating
islands of TB elimination through the deployment of a
comprehensive strategy that includes searching actively
for cases using sensitive diagnostics, treating active cases
as quickly as possible with the correct medications and
preventing disease through the treatment of TB infection
and infection control in congregate settings.2 During
the evaluation period, TB Móvil was implemented by an
intervention team from the non-governmental organisation Socios En Salud in collaboration with the Ministry
of Health, municipal governments and community
organisations.
2

Study population and setting
The intervention area comprised three districts with a
combined population of 1.1 million16 and annual TB
case notification rates of 120–130 per 100 000. TB Móvil
started implementation in February 2019 in northern
Lima. During the first year, the intervention operated for
12 months in Carabayllo District (District A), 9 months
in Comas District (District B) and 3 months in Independencia district (District C).
In the intervention area, TB services are concentrated
in 51 public health facilities operated by the DIRIS Lima
Norte (Dirección de Redes Integradas de Salud Lima
Norte, the regional authority of the Ministry of Health).
The intervention area also contains a regional referral
hospital operated by the Ministry of Health, as well as
a regional hospital and four primary care centres operated by EsSalud, a government insurance programme for
people employed in or retired from the formal economy.
There is no private-sector TB treatment in Peru.17 During
the evaluation period, the routine approach to TB detection was a two-step process of screening for respiratory
symptoms among people seeking care at health facilities
and then using sputum smear microscopy to diagnose
TB; this approach is known to have limited sensitivity.18
Although radiography has higher sensitivity for TB detection, only hospitals and large health facilities had X-ray
capacity.
Intervention
We operated two mobile screening units for 8 hours per
day for 28 days a month, spending the number of months
described above in each district. X-ray vans were equipped
with CAD4TB V.6 (Delft Imaging, ’s-
Hertogenbosch,
Netherlands) automated detection software to efficiently
triage attendees such that only those with abnormal
radiographs consistent with TB underwent further evaluation procedures. We worked with local community
leaders to choose screening locations with high foot
traffic such as parks, community centres and markets. We
partnered with health facility decision-makers to operate
screening sites immediately outside the facility to screen
both health facility attendees and healthcare workers. We
also partnered with transportation companies to operate
screening sites at the terminals of major bus lines with
the goal of making screening accessible to working adults
as they commute. Finally, we partnered with companies
and institutions to screen staff and residents. A structured
community engagement strategy was used to inform
and educate local residents about the programme and
encourage attendance.19
Individuals ≥4 years old were eligible for screening
provided they were not receiving TB treatment (online
supplemental figure S1). Children <4 years old were
eligible for screening only if they were close contacts of
patients with TB; this is because the CAD4TB V.6 software was validated only for individuals ≥4 years old. All
attendees registered for screening, at which point we
collected information on their age, sex and district of
Yuen CM, et al. BMJ Open 2021;11:e050314. doi:10.1136/bmjopen-2021-050314
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of high-risk groups.3 Since effective treatment renders TB
non-infectious,4 active case finding has the potential to
reduce TB transmission by diagnosing people earlier in
their disease course and in larger numbers.
There are many possible approaches to active case
finding, one of which is using mobile units equipped
with X-ray equipment. This strategy can help close the
gap in missed diagnoses both by making it convenient for
people to get screened in their own communities and by
using a sensitive screening method (chest radiography)
that can detect TB before they perceive symptoms.5 In
the 1930s–1960s, mobile X-ray units were an integral part
of TB programmes in industrialised countries.6 7 In the
past decade, some middle-income countries in Asia have
incorporated mobile X-ray units for active case finding
into their TB programmes,8–11 and other countries have
used mobile X-ray units in prevalence surveys and pilot
projects. However, this strategy is not yet used widely in
countries with high TB burdens.
As with the introduction of any new technology, integration of mobile X-ray units into TB programmes that have
never used them comes with implementation challenges.
Implementation research, which systematically and rigorously assesses the implementation of evidence-
based
interventions in real-world settings, can help to guide the
introduction of new practices at a programmatic scale.12
However, as is the case for many TB interventions,13
there is a dearth of implementation research around the
use of mobile X-ray units in communities with high TB
burdens. To address this gap, in Lima, Peru, we used an
implementation science framework to evaluate an active
case-
finding programme that introduced mobile X-
ray
units with computer-aided detection in a setting where
routine TB diagnostic services used a different approach.
We sought to assess the impact of the intervention and to
identify barriers and facilitators to integrating the intervention approach into the local health system.

Open access
among different types of screening sites, using an exact
test for categories with ≤5 sites and considering p<0.05 as
significant.

RE-AIM evaluation
We used the RE-
AIM framework14 to evaluate how
the intervention’s approach to TB active case finding
performed within the Peruvian health system. We chose
the RE-AIM framework because it assesses implementation and effectiveness outcomes at individual and health
system levels, making it well suited for identifying barriers
and facilitators to integrating a new intervention into a
health system. Several components of the intervention
approach differed from routine practice within the local
TB services: (1) screening and evaluation services were
provided within community settings, (2) people without
symptoms or risk factors could be screened, (3)chest radiography was used for screening and to aid diagnosis and
(4) Xpert was used for bacteriological testing. Evaluation
focused on understanding how well the health system
was able to incorporate these new approaches and their
impact on TB diagnosis.

Effectiveness
To assess effectiveness, we considered two main objectives
of active case finding: to diagnose additional cases and to
diagnose cases earlier. To assess additionality, we obtained
quarterly case notifications from Ministry of Health facilities in each of the three districts during 2015–2019.
During this period, there were no major programme-wide
changes to TB services or to the TB surveillance system
in these facilities; nationally, numbers of people evaluated for TB and case notification rates in the Ministry of
Health system remained stable between 2016 and 2019.21
We coded each quarter as preintervention or intervention and calculated the average difference between
actual case notifications during intervention quarters
and expected notifications assuming a linear trend based
on the preintervention quarters; the appropriateness of
a linear trendline was confirmed by plotting residuals of
the linear regression. We included in this analysis only
health facilities that notified TB cases during both the
preintervention and intervention periods to eliminate
bias from changing catchment populations. An overall
effect estimate of the intervention was generated using a
Poisson regression to model quarterly case notifications
during 2016–2019 from each of the three intervention
districts as a function of quarter and whether the intervention was being implemented, using the average quarterly case notifications in 2015 as an offset.
To assess whether cases were diagnosed early, we calculated the percentage of cases that had a positive sputum
smear microscopy result based on the same sputum
sample used for Xpert testing. Smear positivity is associated with increased sputum bacillary load,22 which is
a marker for more advanced disease,23 so a low proportion of smear positivity could indicate earlier diagnosis.
Given that only a single spot sputum sample was tested,
smear microscopy is expected to have lower sensitivity
than under ideal conditions; however, a community-
based screening programme in the Philippines that used
a similar diagnostic algorithm found nearly half of people
diagnosed with TB to have positive smear results based
on the spot sputum specimens collected at the screening
site.8

Reach
To assess reach, we divided the number of people who
registered for screening and who reported living in each
of the three districts by the number of residents in these
districts. We further stratified analysis by age and sex.
We specifically assessed reach among males and people
15–44 years old (referred to as ‘working-age adults’), as
these demographical groups comprise the majority of TB
cases diagnosed in Peru.17 We used a Wilcoxon rank-sum
test to compare the proportion of attendees who were
male and the proportion who were working-age adults

Adoption
We assessed two quantitative measures of adoption. The
first measure was the percentage of health facilities that
accepted having the mobile unit stationed outside to
screen their staff and clients. We considered this to be an
indicator of the acceptability of the intervention to the
health system, which is an important driver of adoption.
The second measure was the time between screening and
treatment initiation for people diagnosed with TB by the
intervention. We considered the promptness of treatment
initiation to be an indicator of the health system’s ability
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residence. After registration, attendees waited for chest
radiography; during the wait time, which ranged from 5
to 50 min depending on attendance, attendees received
education about TB symptoms, transmission, and diagnosis. Chest radiography was performed in the X-ray van
by a radiography technician and scored automatically
by CAD4TB. People with abnormal radiographs were
referred to a physician at the screening unit for clinical
evaluation and were asked for a sputum sample for testing
by GeneXpert MTB/RIF (Cepheid, Sunnyvale, California,
USA; referred to as ‘Xpert’). Field staff used their discretion in requesting sputum from young children given
children’s general inability to produce sputum.20 Xpert
testing was performed at the Socios En Salud laboratory
initially using standard cartridges and switching to ‘Ultra’
cartridges after 6 months. People could be diagnosed with
TB based on a positive Xpert result or by the physician
at the screening unit based on clinical and radiographic
evidence. All people diagnosed with TB were accompanied by community health workers (community members
with basic training in health issues) to public health
facilities for treatment initiation, and radiographs and
Xpert results were given to the health facility doctors. All
procedures were free of cost. Data on all procedures were
directly entered into an electronic data collection system;
data on treatment initiation reflect results obtained by 13
March 2020.

Open access

Implementation
To assess implementation, we quantified performance
indicators using a framework for evaluation of TB active
case finding.25 26 We focused on five key indicators that
reflect implementation fidelity: percentage of people
registered who were screened by chest radiography,
percentage of people with abnormal chest radiographs
who were evaluated clinically, percentage of people with
abnormal chest radiographs who had sputum samples
collected for Xpert testing, percentage of sputum samples
with valid Xpert results and percentage of people diagnosed with TB who initiated treatment. Where any of
these fell below 85%, we probed operational data to identify reasons for suboptimal fidelity. We assessed differences between participant groups by χ2 test.
Maintenance
Our maintenance assessment focused on the extent
to which the intervention was institutionalised into the
routine TB services. Given that the intervention was
grant funded and implemented by an non-governmental
organisation for this first year, the maintenance of the
intervention was dependent on the Ministry of Health
incorporating the approach into its programming. To
assess the extent to which this occurred, we reviewed call
minutes and programme reports from the evaluation

period for evidence of investment by the Ministry of
Health in maintaining or expanding the intervention
beyond the initial year.

RESULTS
Reach
In 1 year, the two mobile units registered 63 899 attendees
at 215 screening locations in north Lima. Of these, 58 962
(92%) reported residing in the intervention area. We estimate that the mobile unit screening reached 6% of residents in the intervention area, including 9% of District
A residents, 4% of District B residents and 3% of District
C residents. The higher coverage in District A was due
to the longer duration of implementation; on average,
the programme reached 3% of District A residents, 2% of
District B residents and 5% of District C residents per 100
days spent in each respective district. Coverage was higher
for females versus males in all districts (A, 11% vs 7%; B,
5% vs 3%; and C, 3% vs 2%; p<0.001 for all comparisons).
Coverage was higher among older adults compared with
younger adults (online supplemental figure S2).
Sites where screening was open to the public included
general community locations, health facilities, markets,
transport terminals and a shopping mall (table 1). At
general community screening sites, a median of 39%
(IQR: 36%–42%) of attendees was male, and a median
of 41% (IQR 36%–44%) of attendees was working-age
adults. In comparison, transport terminal sites had significantly higher percentages of both male attendees and
working-age attendees. In addition, the mobile units were
stationed at five sites where screening was restricted to
staff and residents of specific institutions known to have
predominantly young and male populations, including
an army barrack, a police complex, two companies and a
technical college. These sites also had significantly higher
percentages of male and working-age attendees.
Effectiveness
During the evaluation period, the intervention diagnosed
393 cases of TB, of which 343 (87%) were among people
living in the intervention area. Average case notifications

Table 1 Percentage of male and working-age attendees, by type of screening site
Percentage of male attendees

Percentage of working-age attendees
(age 15–44)

Type of site

Number of sites

Median

IQR

P value

Median

IQR

P value

General community
Health facilities

156
32

39
34

36–42
31–39

Reference
<0.001

41
39

36–44
36–43

Reference
0.508

12

40

37–41

0.528

40

36–44

0.837

Transport terminals

Markets

9

65

62–69

<0.001

46

44–51

<0.001

Company or institution
Shopping mall

5
1

61
38

56–64
N/A

<0.001
0.854

89
61

80–90
N/A

<0.001
0.013

P value from Wilcoxon rank-sum test.
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to incorporate the intervention approach into existing
services. We assessed differences in time to treatment
initiation among patient groups by Wilcoxon rank-sum
test.
To better understand drivers of these two adoption
measures, we qualitatively analysed meeting minutes from
monthly coordination calls (13 documents) and quarterly reports to intervention funders during 2019 (four
documents) using a framework analysis approach.24 We
extracted into matrices all passages related to the intervention coordinators’ interactions with health facilities or
other organisations, as well as passages related to treatment initiation. We then coded these passages according
to whether they described acceptance or rejection of the
intervention or barriers or facilitators to treatment initiation for patients diagnosed by the intervention.

Open access

District A

District B

District C

Average case notifications per preintervention quarter (starting 2015)
Change in cases per quarter based on linear regression

72
+0.6

169
+0.9

79
+0.2

Expected average cases per intervention quarter (2019)

78

177

81

88

184

Actual average cases notified per intervention quarter (2019)
Difference between actual and expected

+13%

Absolute difference in total and expected notifications over all intervention quarters

+41

+19

Cases detected by intervention in residents of district
Estimated percent of cases detected by intervention that represent additional cases

153
27%

159
12%

were 13% higher than expected during four intervention
quarters in District A, 4% higher than expected during
three intervention quarters in District B and 17% higher
than expected during one intervention quarter in District
C (table 2 and online supplemental figure S3). If all additional cases were attributable to the intervention, then an
estimated 27%, 12% and 45% of cases detected by the
intervention in Districts A, B and C, respectively, would
not otherwise have been detected. The overall effect estimate for the intervention was an increase of 11% (95%
CI 6 to 16) in case notifications during quarters when the
intervention was being implemented, after adjusting for
secular changes in case notifications over time.
Of the 393 TB diagnoses, 388 (99%) had a valid Xpert
result, with 315 (81%) having a positive result (including
trace positive results). All 388 also had smear microscopy
performed on the same sputum sample, with only 99
(26%) having a positive result.

+4%

95
+17%
+14
31
45%

Challenges in having diagnoses from the intervention accepted by the health system were documented in
meeting minutes and reports (table 3). One reason for
delay was that people diagnosed with TB were referred for
re-evaluation by pulmonologists at the government hospitals, even if they had positive Xpert results, underlining
a lack of knowledge about this diagnostic test and its
significantly higher sensitivity as compared with sputum
smear microscopy. The utility of education for providers
in reducing treatment delays was also documented. Meetings in which health facility physicians were trained with
regard to the role of radiography and Xpert in TB diagnosis were noted to have improved the acceptability of
diagnoses coming from the intervention and reduced
treatment initiation delays.

Implementation
Of the 63 899 attendees registered over 1 year, 58 268
(91%) had chest radiography performed (figure 1). Each
Adoption
unit performed a median of 114 (IQR 90–134) radioDuring the evaluation period, the intervention team
graphs per day. One new TB diagnosis was made per 148
approached 32 health facilities in the three districts to ask
people screened by chest radiography and one Xpert-
if the mobile unit could be stationed outside the health
positive diagnosis per 44 people tested by Xpert. We were
facility to screen clients and staff. All (100%) accepted.
able to confirm treatment initiation for 323 (82%) of the
These facilities included both hospitals, 29 of the 51
393 TB diagnoses.
(57%) public health facilities overseen by the DIRIS
The two key implementation fidelity indicators that fell
Lima Norte and one of the four (25%) EsSalud primary
below 85% were the percent of people with abnormal chest
care facilities. A report noted that the intervention team
radiographs for whom sputum samples were submitted
received requests for additional screening locations that
and the percent of people diagnosed with TB who initiit could not accommodate (table 3).
ated treatment. When we analysed sputum submission
positive rifampicin- by age, we found that 88% of people age ≥10 years old
Among patients with Xpert-
susceptible TB who initiated treatment, the median time
submitted a sputum sample, compared with 17% of chilfrom screening to treatment initiation was 6 days (IQR
dren <10 years old, suggesting that the suboptimal value
3–11 days). Time to treatment initiation was not signifiof this indicator was driven by young children’s inability
resistant TB
cantly different for those with rifampicin-
to produce sputum.
(median 7 and IQR 3–18 days, p=0.607). However, time to
We found that the percentage of people initiating TB
treatment initiation was longer for those without a positreatment varied depending on the basis of the TB diagtive Xpert result (median 9 and IQR 4–23 days, p=0.026)
nosis (figure 2). Treatment initiation was documented for
and those with trace positive Xpert results (median 11
95% of people with Xpert-positive rifampicin-susceptible
TB. The percentage of people who initiated treatment
and IQR 4–28 days, p=0.003). Given that the median time
was significantly lower for all other types of diagnoses
between screening and Xpert result availability was only 1
(86% for rifampicin-resistant TB, p=0.019; 64% for those
day (IQR 0–1 day), delays in treatment initiation reflected
with trace positive Xpert results, p<0.001; and 53% for
clinical decision delays rather than laboratory delays.
Yuen CM, et al. BMJ Open 2021;11:e050314. doi:10.1136/bmjopen-2021-050314
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Table 2 Impact of intervention based on average quarterly tuberculosis (TB) case notifications in intervention and control
districts during 2015–2019

Open access

RE-AIM construct: theme

Quotation from meeting minutes

Adoption: requests for intervention services
by health system

‘We have received numerous requests to bring the van to screen in different
areas of Lima; although we have not been able to accommodate these requests,
they demonstrate the demand for such services’ (Q1 2019 report)
Adoption: challenges to having TB diagnoses ‘While the screening programme operated successfully, we have encountered
accepted by health system
challenges with delayed treatment initiation for people diagnosed with TB. This
has happened because the doctors are requesting more procedures (such
as CT) before deciding to initiate treatment, and many of them have limited
knowledge of GeneXpert’ (Q4 2019 report)
‘Some people with positive GeneXpert results have to wait to see a
pulmonologist, delaying treatment initiation’ (November 2019 meeting minutes)
Adoption: facilitators to having TB diagnoses ‘We held some meetings with [an infectious disease doctor from the USA] in
accepted
which he talked about GeneXpert Ultra and its use. This helped the doctors in
the primary care facilities of Carabayllo understand better the response to these
cases’ (September 2019 meeting minutes)
Maintenance: expansion of intervention to
other areas with Ministry of Health support

Maintenance: integration of intervention
approach into policy

‘The TB Móvil intervention is being offered to the Ministry of Health in the
municipality of La Victoria’ (January 2020 meeting minutes)
‘There is a possibility that the Ministry of Health will give us access to eight
cases of Xpert cartridges that are currently in another city. The objective is to
use them in north Lima and also other screenings that the Ministry of Health
coordinates. We are discussing whether to do the Xpert testing in the Socios
En Salud laboratory or a Ministry of Health laboratory’ (January 2020 meeting
minutes)
‘We have had meetings with the Ministry of Health and the National TB
Programme in which they expressed interest in developing a directive for TB
active case finding. We presented the approach of TB Móvil. The meeting was
with Dr. X, with whom we have another meeting scheduled for next week to
discuss the coordination of the activities of TB Móvil and the Ministry of Health’
(November 2019 meeting minutes)

RE-AIM, reach, effectiveness, adoption, implementation and maintenance; TB, tuberculosis.

those without a positive Xpert result, who were diagnosed
based on clinical and/or radiographic criteria, p<0.001).
Rejection of the intervention’s TB diagnosis by a heath
facility physician was documented for 9% of those with
trace positive Xpert results and 26% of those without
positive Xpert results.
Maintenance
During the evaluation period, meeting minutes noted
that the Ministry of Health had agreed to let the intervention team use its Xpert machines and cartridges to
expand the screening programme beyond the intervention districts (table 3). A meeting with the National TB
Programme was also reported, which examined the possibility of incorporating the X-ray van strategy into a new
active case-finding policy. As of June 2021 (2.5 years after
the intervention began), the programme had expanded
to 23 additional districts within and outside Lima. After
the end of the original grant-funded period, programme
costs were covered by the Ministry of Health (staff, Xpert
testing and implementation costs), internal funding from
Socios En Salud (staff and implementation costs) and
local municipalities (transport to bring attendees from
underserved areas).
6

DISCUSSION
We found that an intervention using community-based
mobile X-ray screening units was effective for increasing
TB diagnoses and diagnosing TB that was negative by
smear microscopy. In its first year, the intervention
reached 6% of the population of a region of around 1
million inhabitants. The intervention was associated with
an 11% (95% CI 6 to 16) increase in quarterly case notifications after adjusting for the increasing trend in notifications over the previous 4 years. Although decision-makers
at many health facilities were eager to collaborate with the
intervention, we encountered challenges with individual
physicians at local clinics not accepting TB diagnoses
based on X-ray and Xpert. Our experience illustrates the
complexities involved in health system adoption of a new
standard of care that differs substantially from routinised
practice.
The high implementation fidelity we observed for
procedures that took place at the screening site suggests
both demand for free TB diagnostic services and acceptability of mobile X-ray screening units as a way to deliver
these services. Despite long wait times, attendees generally completed the screening and evaluation procedures.
Moreover, high attendance resulted in a large number of
Yuen CM, et al. BMJ Open 2021;11:e050314. doi:10.1136/bmjopen-2021-050314
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Table 3 Observations relating to adoption and maintenance recorded in meeting minutes and reports

Open access

people screened. Our implementation strategy compared
favourably to interventions using mobile X-
ray units
in community settings elsewhere.8 9 27 However, men
and working-age adults were under-represented among
attendees, resulting in uneven reach of the intervention.

Figure 2 Treatment initiation among people diagnosed
with tuberculosis by the intervention, by Xpert result (n=393).
MTB=Mycobacterium tuberculosis; Rif=rifampicin
Yuen CM, et al. BMJ Open 2021;11:e050314. doi:10.1136/bmjopen-2021-050314
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Figure 1 Tuberculosis (TB) diagnostic and treatment
cascade for the TB Móvil screening programme. Green boxes
indicate key implementation indicators.

While offering screening at transport terminals and
places of work increased attendance for both of these
demographical groups, feedback from the implementation team suggested larger structural barriers at play. In
Peru, people working in the informal economic sector
have no protection from loss of income or employment
should they be diagnosed with TB, thus disincentivising
uptake of TB screening. This observation underscores the
importance of legal and social protection programmes,
in addition to expanded case-finding interventions, for
increasing detection of stigmatised diseases like TB.28
The major implementation barriers we encountered
occurred at local health facilities when people diagnosed
with TB by the mobile units went to initiate treatment.
Many TB diagnoses based on trace positive Xpert results
or clinical/radiographic criteria were rejected by the local
physicians, and patients experienced delays in treatment
initiation. Similar challenges were observed in other
countries when Xpert was first introduced as a replacement for smear microscopy. In India, the willingness
of providers to make clinical diagnoses decreased once
Xpert was introduced, in part because Xpert was viewed
as a ‘gold standard’ with perfect sensitivity.29 Moreover,
variable knowledge about Xpert among providers led to
disagreements over the use of Xpert testing for TB diagnosis.30 In other countries, treatment initiation delays for
patients with positive Xpert results were observed because
of confusion over guidelines for reporting Xpert-positive
patients.31 While Xpert had been used at a small scale in
Peru’s public health system prior to the present intervention, a lack of knowledge about Xpert at the primary
care level contributed to some reluctance in accepting
Xpert diagnoses, especially when trace positive results
were obtained. Together, these challenges emphasise
the importance of clear practice guidelines and regular
training for primary-level clinicians when new diagnostic
practices are introduced.
This initial evaluation suggests that the community-
based mobile X-ray unit strategy is effective for increasing
TB case detection in Peru. However, our effectiveness
analysis is subject to some important limitations. While
we used 4 years of case notification data to establish
a temporal trend against which case the intervention
period could be compared, we cannot rule out the possibility that TB programme improvements unrelated to the
intervention might have contributed to an increase in
notifications. Our analysis also cannot explain the heterogeneity of impact in the different districts, particularly
why District B experienced such a small increase in case
notifications despite a large number of TB diagnoses by
the intervention. One possibility is that in District B, security concerns limited programme operation in community
settings, and a larger proportion of people was screened
and diagnosed at sites outside health facilities; because
they were already seeking healthcare, these people might
have been diagnosed by the health system anyway. Finally,
because our intervention introduced multiple components that differed from routine practice, we cannot assess
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effective strategy to extend TB diagnostic services into
communities and improve early case detection. Effective deployment however requires advance coordination
among stakeholders and targeted provider training to
ensure that people diagnosed with TB by new modalities
receive prompt treatment. These implementation lessons
can be applied by other TB elimination coalitions around
the world, as part of the mutual aid and exchange of
resources among coalitions.
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the relative importance of each component. However, it is
likely that the effects of different components depend on
the presence of the others. For instance, in isolation, the
introduction of Xpert into a health system as a replacement for smear microscopy has generally not led to
increases in case detection32 33; however, in our intervention, using Xpert may have contributed to case notifications by providing rapid bacteriological confirmation for
cases that might otherwise have been contested clinical
diagnoses, especially given the low prevalence of smear
positivity.
We did not assess costs in our evaluation. However,
models fit to the epidemics of China and South
Africa—two other upper-
middle-
income countries like
Peru—have suggested that a 2-
year active case-
finding
programme that increases case detection by 25% would
be highly cost-effective at a cost of US$3800–9400 per
case detected.34 If the campaign is sustained for longer
periods of time, they remain highly cost-effective at even
higher costs per case detected, despite declining gains
in case detection over time. Moreover, the health system
strengthening that accompanies the implementation of
a large-scale campaign such as ours also contributes to a
decrease in TB morbidity and mortality, separately from
the intervention itself (Shrestha S, ‘Achieving a “step
change” in the tuberculosis epidemic through comprehensive community-
wide intervention: a model-
based
analysis’).
Other limitations of this initial evaluation reflect time
and resource constraints. We did not perform qualitative
research through interviews or focus groups to better
explain the barriers to adoption of the intervention
approach by the health system. For example, we do not
know whether clinical diagnoses of TB in patients with
clinical and radiographic findings but a negative Xpert
result were rejected because doctors perceived Xpert as
having perfect sensitivity or because of low inter-rater
reliability for chest radiographs, both of which have been
observed in other settings.29 35 In addition, we did not
collect data about the specific healthcare providers or
healthcare facilities managing each patient, which could
have allowed us to determine whether treatment initiation challenges were associated with certain provider or
facility characteristics. Finally, the timeframe of the evaluation limited our ability to quantify durability of impact
over time. Thus, while providing useful knowledge for
integrating mobile X-
ray units into TB programmes
in settings with high TB burdens, our study also highlights areas in which further implementation research is
needed.
Local coalitions seeking to rapidly drive down TB will
have to introduce new strategies to transform routine
services and systems. While new innovations in diagnostic
technologies are needed, increasing and improving the
implementation of evidence-based approaches in settings
with high TB burdens are also important. We found that
deploying mobile X-ray units with automated detection
software across a high-risk area constituted a feasible and
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